Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Fibrosis”

2,342 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,342 results

Not applicableNot Yet RecruitingNCT06872073
What this trial is testing

Assessment of Methotreaxate-induced Liver Fibrosis by Transient Elastography and Serological Markers

Who this might be right for
Liver Fibrosis
Assiut University 144
Large-scale testing (Phase 3)Study completedNCT00039962
What this trial is testing

Thymosin Plus PEG-Interferon in Hepatitis C Patients With Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin

Who this might be right for
Hepatitis CHepatitis C, Chronic
SciClone Pharmaceuticals 500
Large-scale testing (Phase 3)Study completedNCT00240045
What this trial is testing

The Use of Drugs to Improve Kidney Function in Patients With Liver and Kidney Dysfunction

Who this might be right for
Type 2 Hepatorenal SyndromeRefractory Ascites
University of Alberta 9
Not applicableStudy completedNCT02335073
What this trial is testing

Effect of 4 Liver Fibrosis Tests (PIIINP, CIV, LN, and HA) on the Prognosis of Liver Cirrhosis

Who this might be right for
Liver Cirrhosis
General Hospital of Shenyang Military Region 108
Early research (Phase 1)UnknownNCT02652351
What this trial is testing

Human Umbilical Cord-Mesenchymal Stem Cells for Hepatic Cirrhosis

Who this might be right for
Hepatic Cirrhosis
Shenzhen Hornetcorn Bio-technology Company, LTD 20
Large-scale testing (Phase 3)Study completedNCT03067129
What this trial is testing

Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 129
Large-scale testing (Phase 3)Study completedNCT00844402
What this trial is testing

Safety and Efficacy of Long-Term Treatment With Atorvastatin in Patients With Primary Biliary Cirrhosis

Who this might be right for
Primary Biliary CirrhosisHypercholesterolemia
Medical University of Graz 40
Not applicableUnknownNCT03989973
What this trial is testing

Two-dimensional Shear-Wave Elastography Evaluate Esophageal Varices Bleeding Risk of Liver Cirrhosis

Who this might be right for
Liver CirrhosisEsophageal VaricesLiver Stiffness
West China Hospital 500
Testing effectiveness (Phase 2)Ended earlyNCT04065841
What this trial is testing

Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy, Compared With Placebo in Adult Patients With NASH and Liver Fibrosis.

Who this might be right for
Non Alcoholic Steatohepatitis (NASH)
Novartis Pharmaceuticals 234
Not applicableUnknownNCT04764305
What this trial is testing

Liver Disease, Myocardial Fibrosis and Collaterals in the Adult Fontan Patient a Metabolomics and Proteomics Approach

Who this might be right for
Patient ParticipationHeart Defects, CongenitalLiver Diseases+2 more
Medical University Innsbruck 300
Testing effectiveness (Phase 2)Study completedNCT01013194
What this trial is testing

Human Fetal Liver Cell Transplantation in Chronic Liver Failure

Who this might be right for
Liver Cirrhosis
The Mediterranean Institute for Transplantation and Advanced Specialized Therapies 25
Post-approval studies (Phase 4)Study completedNCT03175731
What this trial is testing

PPIs and Gastroesophageal Varices in Liver Cirrhosis (PPIs: Proton Pump Inhibitors)

Who this might be right for
Liver CirrhosisHypertension, Portal
Yanjing Gao 106
Testing effectiveness (Phase 2)Ended earlyNCT04048876
What this trial is testing

Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis

Who this might be right for
Non-alcoholic Fatty Liver DiseaseLiver Cirrhosis
Celgene 56
Large-scale testing (Phase 3)Study completedNCT00736840
What this trial is testing

BreathID 13C-Methacetin Breath Test for Detecting Cirrhosis

Who this might be right for
Chronic Liver Disease
Meridian Bioscience, Inc. 414
Not applicableStudy completedNCT01192698
What this trial is testing

Intravenous Interferon During Liver Transplant

Who this might be right for
Hepatitis CCirrhosis
Wake Forest University Health Sciences 15
Not applicableStudy completedNCT05057572
What this trial is testing

Efficacy and Safety of Carvedilol in Cirrhosis Patients With Uncomplicated Ascites Without High Risk Esophageal Varices

Who this might be right for
Liver Cirrhosis
Institute of Liver and Biliary Sciences, India 104
Early research (Phase 1)Study completedNCT05395481
What this trial is testing

A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)
Eli Lilly and Company 115
Not applicableNot Yet RecruitingNCT07727187
What this trial is testing

Hepatitis B Infection Surveillance

Who this might be right for
Chronic Hepatitis B Infection
Assistance Publique - Hôpitaux de Paris 1,360
Not applicableUnknownNCT02964195
What this trial is testing

Efficacy of Rifaximin in Treatment of Cirrhotic Gastroesophageal Variceal Bleeding

Who this might be right for
CirrhosisEsophageal and Gastric VaricesGastrointestinal Hemorrhage
Shanghai Zhongshan Hospital 308
Testing effectiveness (Phase 2)WithdrawnNCT02965911
What this trial is testing

Efficacy and Safety of Fenofibrate Combined With UDCA in PBC Patients With an Incomplete Biochemical Response to UDCA

Who this might be right for
Primary Biliary Cirrhosis
Beijing 302 Hospital
Next Page